Versalis and Novamont are strengthening their partnership to reinforce synergies in the ecological transition of green chemistry, leveraging what has been built so far to maximize spin-offs and seize new opportunities. The commitment to Matrìca – the joint venture set up in 2011 between Versalis and Novamont at Porto Torres specializing in manufacturing bioproducts from renewable sources – has been reconfirmed.
Versalis, Eni’s chemical company, has begun the production of bioethanol from lignocellulosic biomass at Crescentino (Vercelli, North-western Italy). The plant, which was acquired in 2018, has been overhauled thanks to major investments and has started the production of advanced bioethanol, in compliance with the European legislation for the development of renewable energy RED II, as it is derived from raw materials that do not interfere with the food chain.
Versalis, Eni’s chemical company, and BTS Biogas, an Italian company in the building and managing sector of biogas plants, have agreed to develop and commercialise an innovative technology for the production of biogas and biomethane from residual lignocellulosic biomass.
“Another main pillar of our strategy is to drive sustainability through chemistry from renewable sources. We already operate on two technological platforms: Proesa® starting from solid biomasses and Matrìca from vegetable oils.” Adriano Alfani, CEO Versalis – the chemical division of Italian oil company ENI, talks to Il Bioeconomista.
Interview by Mario Bonaccorso
Versalis Sunpower is the name of the broad spectrum herbicide from renewable sources marketed by Versalis that controls annual and perennial weeds in urban and industrial areas. From pelargonic acid produced at the Porto Torres, Sardinia, plant, Versalis, based on the agreement with AlphaBio Control, a research and development company specialized in the creation of natural formulations for crop protection, offers to the market the product derived from vegetable oils which controls weeds by acting in synergy with solar radiation.
Versalis enters the market for bio-based products in the agriculture sector for the protection of crops. Thanks to an agreement with AlphaBio Control, a research and development company with offices in the United Kingdom and Italy specialised in the production of natural formulations for the protection of crops with its products already known in the pesticides market, Eni’s chemical company will develop bio-based and biodegradable herbicides and also biocides for the disinfection of surfaces, using as active ingredient productions from the bio-chemical platform in Porto Torres, Sardinia.
Versalis, Eni’s chemical company, has launched a new line to produce liquid hand disinfectant marketed under the brand name Invix™ at its plant in Crescentino (Vercelli, North-western Italy), to meet the growing demand as a result of the current health situation across the nation.
Versalis, the chemical division of the Italian oil company Eni, confirms that it is in the process of implementing an action plan that will lead to a resumption of operations at the former biorefinery of Mossi Ghisolfi Group in Crescentino, which were acquired in November 2018. New 35 hires are expected by the end of the year.
“The bioeconomy offers great opportunities for the European chemical industry to create new products, diversify its raw material base and reduce its dependence on non-renewable resources”. To say it – in this long exclusive interview with Il Bioeconomista – is Daniele Ferrari, CEO Versalis, the Chemical Division of Italian oil giant ENI, and President CEFIC, the European Chemical Industry Council. Ferrari talks with us about the main challenges the European chemical industry is facing, the circular bioeconomy and the next steps of Versalis in the green chemistry field.
Interview by Mario Bonaccorso
“The Ipo (Initial public offering, editor’s note) of Versalis is not yet in Eni’s plans”, Massimo Mondazzi, CFO of the Italian oil giant, said last Friday during a conference call with analysts answering the question about the chemical quotation hypothesis. “We want to maintain and strengthen Versalis, there are no Ipo projects. The option is not in the plans,” he said.